Clinical and Experimental Metastasis

Top Research Topics at Clinical & Experimental Metastasis?

The topics of Internal medicine, Metastasis, Cancer research, Pathology and Surgical oncology are the focal point of discussions in Clinical & Experimental Metastasis. Clinical & Experimental Metastasis explores issues in Internal medicine which can be linked to other research areas like Endocrinology and Oncology. Topics in Metastasis were tackled in line with various other fields like Cancer cell, Melanoma and In vivo.

The Cancer research works featured in the journal incorporate elements from Cell culture, Cell, Cell growth, Immunology and Tumor progression. The concepts on Cell culture presented in it can also apply to other research fields, including Molecular biology, In vitro and Cell biology. While Molecular biology is the focus of it, it also provided insights into the studies of Biochemistry, Matrix metalloproteinase and Transfection.

The research on Cell biology tackled can also make contributions to studies in the areas of Integrin and Cell adhesion. Some problems in Pathology that were presented in it overlapped with concepts under Angiogenesis and Bone metastasis. Topics in Surgical oncology explored in Clinical & Experimental Metastasis were investigated in conjunction with research in Radiation therapy, Radiology, Colorectal cancer and Chemotherapy.

• Internal medicine (41.30%)
• Metastasis (41.17%)
• Cancer research (35.82%)

What are the most cited papers published in the journal?

• Acidic pH enhances the invasive behavior of human melanoma cells. (422 citations)
• The actin cytoskeleton in cancer cell motility. (397 citations)
• Invadopodia: specialized cell structures for cancer invasion. (357 citations)

Research areas of the most cited articles at Clinical & Experimental Metastasis:

The published papers mainly deal with areas of study such as Metastasis, Cancer research, Pathology, Internal medicine and Surgical oncology. While work presented in the most cited articles provide substantial information on Metastasis, it also covers topics in Cancer cell, Extracellular matrix, Breast cancer and Cell adhesion. The most cited publications focus on Internal medicine but the discussions also offer insight into other areas such as Endocrinology and Oncology.

What topics the last edition of the journal is best known for?

• Cancer
• Gene
• Internal medicine

The previous edition focused in particular on these issues:

The journal was organized to reinforce research efforts on Surgical oncology, Internal medicine, Cancer, Metastasis and Hematology. The research on Surgical oncology featured in it combines topics in other fields like Circulating tumor cell, Lung cancer, Radiology, Disease and Breast cancer. Clinical & Experimental Metastasis focused on Internal medicine research but expanded to cover Oncology.

In it, Lymphatic system, Melanoma and Intensive care medicine are investigated in conjunction with one another to address concerns in Cancer research. While the journal focused on Metastasis, it was also able to explore topics like Smac Mimetic LCL161, Extracellular matrix, Cancer research and Lymph node. It focuses on Cancer research but the discussions also offer insight into other areas such as Cancer cell and Bone metastasis.

The most cited articles from the last journal are:

• CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells. (3 citations)
• Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer. (3 citations)
• Electrochemotherapy of skin metastases from breast cancer: a systematic review (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Clinical & Experimental Metastasis (based on the number of publications) are:

• Danny R. Welch (39 papers) published 1 paper at the last edition the same number as at the previous edition,
• Garth L. Nicolson (29 papers) absent at the last edition,
• Erik W. Thompson (25 papers) absent at the last edition,
• Garth L. Nicolson (22 papers) absent at the last edition,
• Jonathan P. Sleeman (22 papers) published 2 papers at the last edition, 2 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical & Experimental Metastasis (based on the number of publications) are:

• University of Texas MD Anderson Cancer Center (94 papers) absent at the last edition,
• National Institutes of Health (58 papers) absent at the last edition,
• University of Texas at Austin (42 papers) absent at the last edition,
• University of Alabama at Birmingham (31 papers) published 1 paper at the last edition,
• Heidelberg University (30 papers) published 4 papers at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.94% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 10.34% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.90% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 25.86% of all publications and 56.90% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Relation of Research Topics with Nursing

Nursing, as a profession, has a significant link with the research topics mentioned in the text. The practical application of discoveries in Internal Medicine, Metastasis, Cancer Research, Pathology, and Surgical Oncology greatly benefits nursing practices, enhancing patient care quality and disease control rates.

Nurses are often directly involved in the application of these research findings in the clinical setting, particularly through patient management methods, personalized treatment strategies, and innovative therapeutic interventions for various conditions such as Metastasis and Cancer. Therefore, understanding these research topics is crucial for nurses, and consequently, the instruction patterns in nursing institutions.

It is quite evident that nursing schools adapting their curriculum to incorporate these emerging research areas can provide their students with an edge in the medical field. With Idaho harboring several prestigious institutions offering nursing degrees, prospective students can explore a compiled list of the best nursing schools in Idaho that are integrating these advanced research topics into their nursing programs.

These schools are well-equipped to provide quality education that covers these significant research areas. An understanding of these subjects will allow nurses to provide better patient care, enhanced therapeutic interventions, and improved health outcomes, forming the backbone of any successful healthcare setting.